Form EFFECT Astria Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 27, 2026 |
| Accession Number: | 0001140361-26-002205 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- International Paper CEO to Speak at Jefferies 2026 Industrials Conference
- HelloNation Features Radon Mitigation Expert Paul Nicholson on Radon Mitigation Guarantees
- Legacy Health Works LLC Announces Kylar Denae Williams, 2024 University of Arkansas Graduate, as Chief Executive Officer of the Family-Built, AI-Infused Healthcare Company
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
